The Lagos state suspected cholera cases have risen to 421.
The Commissioner for Health, Akin Abayomi disclosed this on his Instagram handle @profakinabayomi on Saturday.
“As of June 20, 2024, an additional four suspected cholera cases have been reported, as illustrated in the accompanying graph,” he wrote.
He noted that the Emergency Operations Centre in collaboration with all relevant partners is actively engaged in contact tracing, community-based surveillance, awareness campaigns, sample testing, and ensuring that confirmed cholera cases receive appropriate medical treatment.
On Friday, the commissioner confirmed 35 cases out of the 417 suspected cases and 24 deaths across 20 Local Government Areas in the state.
The cases were reported from Agege, Badagry, Ikeja, Mushin, Ajeromi-Ifelofun, Epe, Ikorodu, Ojo, Alimosho, and Eti-Osa.
Others were Kosofe, Oshodi-Isolo, Amuwo-Odofin, Ibeju-Lekki, Lagos Island, Shomolu, Apapa, Ifako-Ijaiye, Lagos mainland, and Surulere.Related News
Cholera is a food and water-borne disease caused by ingesting the bacteria— Vibrio cholerae — in contaminated water and food. Cholera can cause severe acute watery diarrhoea, and the severe forms of the disease can kill within hours if left untreated.
In Nigeria, cholera is an endemic and seasonal disease, occurring annually mostly during the rainy season and more frequently in areas with poor sanitation.
The World Health Organisation on Thursday announced a spike in cholera in several regions of the world, with almost 195,000 cases and over 1,900 deaths reported in 24 countries since the start of 2024.
WHO said the Eastern Mediterranean Region reported the highest number of cases, followed by the African Region, the Region of the Americas, the Southeast Asia Region, and the European Region.
The global health body, however, noted that there are no reported cases in the Western Region, according to its bulletin released on Wednesday.
It said it exhausted its global stockpile of Oral Cholera Vaccines by March but was able to exceed “the emergency target of five million doses in early June for the first time in 2024.”
